Frazier Life Sciences Management’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63M | Sell |
970,130
-178,461
| -16% | -$1.04M | 0.23% | 44 |
|
|
2025
Q1 | $3.24M | Hold |
1,148,591
| – | – | 0.15% | 46 |
|
|
2024
Q4 | $7.9M | Hold |
1,148,591
| – | – | 0.33% | 39 |
|
|
2024
Q3 | $20.9M | Hold |
1,148,591
| – | – | 0.84% | 27 |
|
|
2024
Q2 | $21.8M | Hold |
1,148,591
| – | – | 1.02% | 27 |
|
|
2024
Q1 | $24.8M | Buy |
1,148,591
+267,418
| +30% | +$5.78M | 1.05% | 28 |
|
|
2023
Q4 | $15.3M | Hold |
881,173
| – | – | 0.82% | 34 |
|
|
2023
Q3 | $8.66M | Hold |
881,173
| – | – | 0.58% | 33 |
|
|
2023
Q2 | $4.85M | Hold |
881,173
| – | – | 0.29% | 42 |
|
|
2023
Q1 | $5.46M | Hold |
881,173
| – | – | 0.4% | 41 |
|
|
2022
Q4 | $13.4M | Hold |
881,173
| – | – | 0.84% | 24 |
|
|
2022
Q3 | $8.7M | Hold |
881,173
| – | – | 0.67% | 32 |
|
|
2022
Q2 | $10.4M | Hold |
881,173
| – | – | 0.99% | 28 |
|
|
2022
Q1 | $16.7M | Buy |
+881,173
| New | +$16.7M | 1.43% | 22 |
|